Synergy

Категория: Системы стентирования коронарных артерий

Система стента SYNERGY™ представляет собой коронарный стент с эверолимусом и биоразлагаемым полимером на платино-хромовой основе. Стент отличается инновационной технологией аблюминального нанесения полимера, который полностью рассасывается через 3 месяца после высвобождения препарата.

Система оснащена усовершенствованной системой доставки с лазерной резкой гипо tube, обеспечивающей исключительную управляемость. SYNERGY™ также доступен в длине 48 мм — первом и единственном стеnte с биоразлагаемым полимером такой длины.

Описание

SYNERGY™

Monorail
Everolimus-Eluting Platinum Chromium Coronary Stent System

Zero in on Safety. Heal With Confidence.

The SYNERGY™ Bioabsorbable Polymer Stent comes with Synchrony bioabsorbable polymer coating on the abluminal side. Polymer is gone when no longer needed, shortly after completion of drug elution at 3 months. Providing Suppression of neointimal growth at the arterial wall & Promotion of healing inside the lumen.

The SYNERGY™ Stent System is equipped with a delivery system having new Laser-cut hypotube technology which provides exceptional deliverability by improving pushability and trackability.

Exceptional Deliverability

Synergy™ stent system comes with New laser-cut Hypotube technology having ~300 cuts over 100 mm length. It Extends into midshaft to exit port to improve pushability. Additional length maintains midshaft flexibility.

Laser-cut hypotube provides exceptional deliverability by improving pushability and trackability.

SYNERGY™ 48 mm

Long lesions represent a complex lesion subset that is associated with increased safety related events, reduced efficacy and increased procedure time.

Early Healing

Abluminal bioabsorbable polymer (BP) application

Emphasizes suppression of neointimal growth at the arterial wall while promoting healing inside the vessel.

Thin, rounded struts

Stents with thinner strut designs have been shown to heal faster than thicker strut stents.¹

Fast-absorbing bioabsorbable polymer

Polymer is gone when it is no longer needed, shortly after the drug is completely eluted.²

Optimal drug release

Market-leading Everolimus drug is completely eluted with optimal kinetics at 3 months.

Clinical Outcomes

The SYNERGY™ BP Stent demonstrates consistently low stent thrombosis rates in over 18,000 patients across 9 studies

ARC ST (Def) Rates for the SYNERGY™ BP Stent¹⁷

Low late and very late ST rates across multiple trials.

Дополнительные материалы

Диаметр (mm)	8 mm	12 mm	16 mm	20 mm	24 mm	28 mm	32 mm	38 mm	48 mm	Возможность перерасширения
2.25	H7493926208220	H7493926212220	H7493926216220	H7493926220220	H7493926224220	H7493926228220	H7493926232220	H7493926238220		3.50
2.50	H749392621N1250	H7493926212250	H7493926216250	H7493926220250	H7493926224250	7493926228250	H7493926232250	H7493926238250	H7493926248250	3.50

Диаметр (mm)	8 mm	12 mm	16 mm	20 mm	24 mm	28 mm	32 mm	38 mm	48 mm	Возможность перерасширения
2.75	H749392fi200270	H7493926212270	H7493926216270	H7493926220270	H7493926224270	H749392622B270	H7493926232270	H7493926238270	H7493926248270	3.50
3.00	H749392fi208300	H7493926212300	H7493926216300	H7493926220300	H7493926224300	H7493926228300	H7493926232300	H7493926238300	H7493926248300	4.25

Диаметр (mm)	8 mm	12 mm	16 mm	20 mm	24 mm	28 mm	32 mm	38 mm	48 mm	Возможность перерасширения
3.50	H7493921i208350	H7493926212350	H7493926216350	H7493926220350	H7493926224350	H74939?.6228350	H7493926232350	H7493926238350	H7493926248350	4.25
4.00	H749392fi208400	H7493926212400	H7493926216400	H7493926220400	H7493926224400	H7493926228400	H7493926232400	H7493926238400	H7493926248400	5.75
4.50		H7493926212450	H7493926216450	H7493926220450	H7493926224450	H7493926228450	H7493926232450			5.75
5.00		H7493926212500	H7493926216500	H7493926220500	H7493926224500	H7493926228500	H74939262J2500			5.75

Брошюра